Last reviewed · How we verify

NCT06171373

Extension for Menopause Sample Collection

Completed Last updated 13 May 2025
What this trial tests

trial in Menopause in 34 participants. Completed in 7 May 2025.

Timeline
22 January 2024
Primary endpoint
7 May 2025
7 May 2025

Quick facts

Lead sponsorSPD Development Company Limited
StatusCompleted
Study typeOBSERVATIONAL
Enrollment34
Start date22 January 2024
Primary completion7 May 2025
Estimated completion7 May 2025
Sites1 location across United Kingdom

Conditions studied

Sponsor

SPD Development Company Limited

Who can join

18 and older, female only, with Menopause. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will provide urine samples from women going through the menopause transition in order to maintain the SPD sample bank. Symptom information and cycle length will also be recorded to observe how these change through the menopause transition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Menopause

Currently open trials in the same condition.

Other SPD Development Company Limited trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06171373.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing